PFE · 10-Q · 2026Q3 · Full report
Intangible Asset Impairments
PFIZER INC · 2026-11-03 · Importance 69 · Surprise 64 · Matches filing data
For the nine months ended September 27, 2026, Pfizer’s reconciliation included a $4.325 billion adjustment for certain asset impairments. The comparable 2025 nine-month reconciliation showed a $577 million adjustment for certain asset impairments. Pfizer also identified higher non-cash intangible-asset impairments as a factor affecting 2026 net income in its operating-cash-flow discussion.
Key facts
- For the nine months ended September 27, 2026, Pfizer recorded a $4.325 billion certain-asset-impairment adjustment in other income/deductions, with a corresponding $4.325 billion adjustment to net income attributable to common shareholders. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | negative | realized | -26.1% | For the nine months ended September 27, 2026, Pfizer recorded a $4.325 billion certain-asset-impairment adjustment in other… |
| assets | negative | realized | -2.1% | For the nine months ended September 27, 2026, Pfizer recorded a $4.325 billion certain-asset-impairment adjustment in other… |